Targeting cellular adaptive responses to glutaminolysis perturbation for cancer therapy

Area of Science:

• Oncology
• Cancer Metabolism
• Molecular Biology

Background:

• Metabolic reprogramming, particularly glutamine metabolism, is fundamental to cancer cell proliferation and survival.
• Targeting cancer cell dependency on glutamine metabolism is a therapeutic strategy.
• Cancer cells develop adaptive responses that confer resistance to these therapies.

Purpose of the Study:

• To review the adaptive mechanisms cancer cells employ to survive and grow when glutamine metabolism is disrupted.
• To highlight key pathways and processes involved in cancer cell adaptation.

Main Methods:

• Literature review focusing on adaptive responses to glutamine metabolism disruption.
• Analysis of the roles of specific molecular players and pathways.

Main Results:

• Cancer cells utilize transcription factors, metabolic pathway alterations, mTORC1 signaling, autophagy, macropinocytosis, nucleotide biosynthesis, and ROS scavenging to adapt.
• These adaptive mechanisms are crucial for maintaining cancer cell survival and growth.

Conclusions:

• Understanding and targeting these multifaceted adaptive responses is critical for overcoming therapeutic resistance.
• Targeting glutamine metabolism adaptation presents a promising strategy for enhancing cancer treatment efficacy.